When to Increase Your Mounjaro Dose for Weight Loss: What NHS Guidance Says

Step 1: Starting at 2.5 mg and understanding why the first pen is not a therapeutic dose

The first four weeks on Mounjaro are an adjustment period. The 2.5 mg starting dose exists primarily to settle your digestive system into the medicine's effects, slowed gastric emptying and increased fullness can catch the body off guard, and the lower dose keeps early nausea manageable. Most people notice the GI effects most sharply in the first week or two, then find they ease.

Because 2.5 mg is a tolerability dose rather than the dose that drives meaningful weight change, it is normal to see only modest results at this stage. That is expected and is not a reason to push upward early. The NHS guidance on tirzepatide specifies a minimum of four weeks at each dose level before any increase is considered.

Practically, this means your first clinical review falls around week four. Your prescriber will ask about GI symptoms, how your appetite has changed, any injection-site reactions, and whether anything in your health picture has shifted. Think of it less as a tick-box and more as a real conversation, the sort our clinical team has with patients every day.

Step 2: The four-week minimum at every rung (and what delays a step up

Each dose tier) 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg, requires at least four weeks before moving higher. Two things must both be true before an increase is appropriate: the current dose is well tolerated, and there is no clinical reason to pause.

If nausea, vomiting, diarrhoea or reflux are still significant, the sensible move is to stay at the current dose for another four weeks rather than escalate. Some people remain at 5 mg or 7.5 mg for longer than the minimum and do well there; there is no clinical prize for reaching 15 mg as quickly as possible. The SURMOUNT-1 trial, published in the New England Journal of Medicine, showed meaningful average weight reductions at multiple dose levels, not only at the maximum, so the highest dose is not universally necessary.

For anyone wondering about the NHS route specifically, our page on Mounjaro on the NHS covers how the phased rollout affects who qualifies and when, relevant context if you are trying to understand how NHS and private prescribing compare on titration oversight.

Step 3: The 6-month review and the NICE 5% rule

Beyond the per-step checks, NICE guidance (TA1026) sets a formal review point at six months on the highest tolerated dose. If weight loss at that stage is below 5% of starting body weight, the evidence base for continuing treatment weakens and the prescriber will discuss whether to continue, adjust the approach, or stop.

This is not a punishment clause, it is a recognition that Mounjaro works well for most people but not identically for everyone. For the majority, six months on an effective dose produces well above 5% loss; the SURMOUNT clinical programme reported average reductions of around 20% at 15 mg over 72 weeks in people without diabetes. The 5% threshold is the floor, not the ceiling.

If you are curious about the full cost picture of a private titration journey, our Mounjaro cost guide lays out what private treatment pricing typically looks like across doses and providers, useful context before you commit to a longer course. And if you want to understand the safety profile before or after a dose change, our safety overview covers what to watch for at each stage.

What this means if you are using a private online pharmacy

The titration logic above is the same whether you are on an NHS pathway or a private one, the medicine's licensed schedule does not change. What differs is the mechanism of review. If you are still weighing up your options at the very beginning, our guide on where to get Mounjaro for weight loss explains the different settings available, from specialist clinics to regulated online pharmacies, so you can choose the right fit before committing. On the NHS, your GP or specialist team manages the steps. Through a regulated private pharmacy, each dose increase requires fresh clinical evidence: a prescriber reviews your progress, checks your current weight, and assesses whether moving up is appropriate.

At nume, that review happens before every repeat order. There is no auto-renewal, no algorithm signing off your next pen. A GPhC-registered prescriber reads your update the same day, so if you order before noon on a working day and your dose increase is clinically supported, the next pen ships that afternoon and arrives with DPD the following working day, in plain packaging. Some patients tell us the bit they least expected was how quick that review was. If you are at the stage of thinking about starting or switching, our page on how to get Mounjaro for weight loss walks through the full private route, and if cost or eligibility makes the NHS option worth exploring first, our page on whether you can get Mounjaro on the NHS for weight loss sets out exactly who currently qualifies and how the process works. Eligibility criteria, the consultation process and what to have ready are all covered there.

Ready to have your current dose or next step reviewed by a clinician? Start your free consultation and a prescriber will assess your situation the same day.